Moderna· @moderna_tx · X·· 2026-08-06精选AI 评分70
AI 导读
Moderna 宣布美国 FDA 已批准其季节性流感疫苗 mFLUSIVA（mRNA-1010），用于 50 岁及以上所有成人。该批准是在 FDA 疫苗与相关生物制品咨询委员会一致推荐支持该疫苗用于 50 岁及以上成人之后作出的。
推荐理由
Moderna 的 mRNA 流感疫苗获 FDA 批准，读者可据此了解 mRNA 技术向流感疫苗领域的延伸。
正文
Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.
This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee supporting mFLUSIVA for adults 50 years of age and older.
Read more: https://feeds.issuerdirect.com/news-release.html?newsid=4801915282452025&symbol=MRNA
来源：Moderna · x.com